skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

What's New in the Guidelines

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and treatment recommendations occur.

The editors and subject matter experts are committed to timely changes in this document because so many health care providers, patients, and policy experts rely on this source for vital clinical information.

All changes are developed by the subject matter groups listed in the document (changes in group composition are also promptly posted). These changes are reviewed by the editors and by relevant outside reviewers before the document is altered.

Major revisions within the last 6 months are as follows:

August 17, 2016

  1. Cryptococcosis: In this revision, new data is cited that found that there was no improvement with the addition of a six-week tapering course of dexamethasone to antifungal therapy among African and Asian patients with cryptococcal meningitis. This supports the current guideline recommendations to not use corticosteroids in cryptococcal meningitis in the absence of the immune response inflammatory syndrome.

May 3, 2016

  1. Bacterial Enteric Infections: This section has been updated to include new information on the growing issue of antibiotic resistance among enteric bacteria as well as updated information on treatment of enteric infections, including in pregnant women.

Back to Top